BetaEntity Annotation Prototype
← Back to funders

Annotated abstract

Vinay Prasad leaves FDA again amid dispute over Huntington’s disease treatment

bmj · 2026-03-09 · canonical JSON source

2 visible annotations · policy: published · automated confidence ≥ 75.00%

Document resource

Vinay Prasad, the US Food and Drug Administration chief medical and scientific officer, will leave the agency for the second time, amid a series of disputes with pharmaceutical companies.